Head and Neck Carcinoma — Trials

Head and Neck Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,921 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,013
Recruiting: 534
Ph III recruiting: 91
Growth YoY: +21.4%
Industry share: 20%
Top sponsor: Sun Yat-sen University
Termination share: 33.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (347)

clinicaltrialsPublishedShowing 101–150 of 202 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04955886	Surufatinib Combined With Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma	unknown	Phase 2	14	Fujian Cancer HospitalOTHER_GOV	1	Jul 9, 2021	clinicaltrials
NCT03904225	Tegio Consolidation Therapy for NPC Patients With High Risk of Metastasis	unknown	Phase 2	220	Zhejiang Cancer HospitalOTHER	1	Jun 23, 2021	clinicaltrials